Sami Ventelä

Dr. Sami Ventelä

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2003 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
PDF file
SVSami Ventelä
Sami Ventelä
JTJorma Toppari
Jorma Toppari
MPMartti Parvinen
Martti Parvinen
Stable cytoplasmic bridges (or ring canals) connecting the clone of spermatids are assumed to facilitate the sharing of haploid gene products and synchronous development of the cells. We have visualized these cytoplasmic bridges under phase-contrast optics and recorded the sharing of cytoplasmic material between the spermatids by a digital time-lapse imaging system ex vivo. A multitude of small (ca. 0.5 μm) granules were seen to move continuously over the bridges, but only 28% of those entering the bridge were actually transported into other cell. The average speed of the granules decreased significantly during the passage. Immunocytochemistry revealed that some of the shared granules contained haploid cell-specific gene product TRA54. We also demonstrate the novel function for the Golgi complex in acrosome system formation by showing that TRA54 is processed in Golgi complex and is transported into acrosome system of neighboring spermatid. In addition, we propose an intercellular transport function for the male germ cell-specific organelle chromatoid body. This mRNA containing organelle, ca. 1.8 μm in diameter, was demonstrated to go over the cytoplasmic bridge from one spermatid to another. Microtubule inhibitors prevented all organelle movements through the bridges and caused a disintegration of the chromatoid body. This is the first direct demonstration of an organelle traffic through cytoplasmic bridges in mammalian spermatogenesis. Golgi-derived haploid gene products are shared between spermatids, and an active involvement of the chromatoid body in intercellular material transport between round spermatids is proposed.

4 August 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
RKRiina Kaukonen
Riina Kaukonen
AMAnja Mai
Anja Mai
MGMaria Georgiadou
Maria Georgiadou
MSMarkku Saari
Markku Saari
NFNicola De Franceschi
Nicola De Franceschi
JIJohanna Ivaska
Johanna Ivaska
Tissue homeostasis is dependent on the controlled localization of specific cell types and the correct composition of the extracellular stroma. While the role of the cancer stroma in tumour progression has been well characterized, the specific contribution of the matrix itself is unknown. Furthermore, the mechanisms enabling normal—not cancer—stroma to provide tumour-suppressive signals and act as an antitumorigenic barrier are poorly understood. Here we show that extracellular matrix (ECM) generated by normal fibroblasts (NFs) is softer than the CAF matrix, and its physical and structural features regulate cancer cell proliferation. We find that normal ECM triggers downregulation and nuclear exit of the histone demethylase JMJD1a resulting in the epigenetic growth restriction of carcinoma cells. Interestingly, JMJD1a positively regulates transcription of many target genes, including YAP/TAZ (WWTR1), and therefore gene expression in a stiffness-dependent manner. Thus, normal stromal restricts cancer cell proliferation through JMJD1a-dependent modulation of gene expression.

1 June 2011 in Oral Oncology
Verified
Journal Article
Closed access
LKLinda-Lotta Kokko
Linda-Lotta Kokko
SHSaija Hurme
Saija Hurme
SMSanna-Mari Maula
Sanna-Mari Maula
KAKalle Alanen
Kalle Alanen
RGReidar Grénman
Reidar Grénman
SVSami Ventelä
Sami Ventelä

26 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SVSami Ventelä
Sami Ventelä
CCChristophe Côme
Christophe Côme
JMJuho-Antti Mäkelä
Juho-Antti Mäkelä
RHRobin M Hobbs
Robin M Hobbs
LMLeni Mannermaa
Leni Mannermaa
Jukka WestermarckJukka Westermarck
Jukka Westermarck
Protein phosphatase 2A (PP2A) is a critical regulator of protein serine/threonine phosphorylation. However, the physiological and developmental roles of different PP2A complexes are very poorly understood. Here, we show that a newly characterized PP2A inhibitory protein CIP2A is co-expressed with ki-67 and with self-renewal protein PLZF in the spermatogonial progenitor cell (SPC) population in the testis. CIP2A and PLZF expression was shown also to correlate Ki-67 expression in human testicular spermatogonia. Functionally, CIP2A mutant mouse testes exhibited smaller number of PLZF-positive SPCs and reduced sperm counts. Moreover, seminiferous tubuli cells isolated from CIP2A mutant mice showed reduced expression of Plzf and other renewal genes Oct-4 and Nanog at mRNA level. However, PLZF-deficient testes did not show altered CIP2A expression. Importantly, spermatogonia-specific restoration of CIP2A expression rescued PLZF expression and sperm production defects observed in CIP2A mutant mice. Taken together, these results reveal first physiological function for an emerging human oncoprotein CIP2A, and provide insights into maintenance of PLZF-positive progenitors. Moreover, demonstration that CIP2A expression can be systematically inhibited without severe consequences to normal mouse development and viability may have clinical relevance regarding targeting of oncogenic CIP2A for future cancer therapies.

9 April 2012 in Stem Cells
Verified
Journal Article
Open access
PDF file
SVSami Ventelä
Sami Ventelä
JMJuho‐Antti Mäkelä
Juho‐Antti Mäkelä
JKJarmo Kulmala
Jarmo Kulmala
Jukka WestermarckJukka Westermarck
Jukka Westermarck
JTJorma Toppari
Jorma Toppari
The ability of spermatogonial stem cells to acquire embryonic stem cell (ESC) properties in vitro has recently been of great interest. However, studie

5 December 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
SVSami Ventelä
Sami Ventelä
ESEleonora Sittig
Eleonora Sittig
LMLeni Mannermaa
Leni Mannermaa
JMJuho-Antti Mäkelä
Juho-Antti Mäkelä
JKJarmo Kulmala
Jarmo Kulmala
Jukka WestermarckJukka Westermarck
Jukka Westermarck
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance